A combination of temsirolimus, an allosteric mTOR inhibitor, with clofarabine as a new therapeutic option for patients with acute myeloid leukemia.
Chiarini F, Lonetti A, Teti G, Orsini E, Bressanin D, Cappellini A, Ricci F, Tazzari PL, Ognibene A, Falconi M, Pagliaro P, Iacobucci I, Martinelli G, Amadori S, McCubrey JA, Martelli AM.
Chiarini F, et al. Among authors: tazzari pl.
Oncotarget. 2012 Dec;3(12):1615-28. doi: 10.18632/oncotarget.762.
Oncotarget. 2012.
PMID: 23271044
Free PMC article.